Anlon Healthcare IPO GMP Today: Grey Market Premium, Listing Gain Estimate & Updates
Anlon Healthcare IPO GMP Today (August 25, 2025)
Anlon Healthcare IPO GMP Today (August 25, 2025)
As of August 25, 2025, the Anlon Healthcare IPO grey market premium is trending between ₹20–₹25, indicating strong investor interest. With a price band of ₹86–₹91, this translates to an estimated listing gain of 22%–27%, projecting a potential listing price near ₹111–₹116.
Anlon Healthcare IPO GMP Trend & Updates
|
Date |
GMP (₹) |
Estimated Listing Price (₹) |
Listing Gain (%) |
|
22 Aug |
₹18 |
₹109 |
~20% |
|
23 Aug |
₹22 |
₹113 |
~24% |
|
24 Aug |
₹25 |
₹116 |
~27% |
|
25 Aug |
₹20 |
₹111 |
~22% |
Anlon Healthcare IPO Details
Price Band: ₹86–₹91 per share
Issue Size: ₹121.03 crore (Fresh Issue only)
IPO Dates: August 26–29, 2025
Lot Size: 164 shares
Listing Date: September 3, 2025
Registrar: Kfin Technologies
Lead Manager: Interactive Financial Services Ltd.
Retail Quota: 10% only
Anlon Healthcare IPO GMP vs Peers
Compared to recent SME and healthcare IPOs, Anlon Healthcare’s GMP is above average, driven by:
- Attractive valuation (P/E of 14.26x vs industry average of 28x)
- Strong financial growth (PAT up 105% YoY)
- Diversified product portfolio with 65 commercialized APIs
- Global DMF approvals (Brazil, China, Japan)
Should You Invest Based on GMP?
Short-Term View: Yes. The current GMP trend and low retail quota suggest strong listing gains and potential oversubscription.
Long-Term View: Promising fundamentals, but investors should monitor regulatory risks, working capital needs, and execution of expansion plans.
FAQs on Anlon Healthcare IPO GMP
What is Anlon Healthcare IPO GMP today?
Currently, the GMP is around ₹20–₹25, indicating a listing gain of 22%–27%.
Is Anlon Healthcare IPO GMP high?
Yes. It’s considered strong for a ₹91 issue price, especially in the SME pharma segment.
Anlon Healthcare IPO GMP compared to peers?
Higher than average, outperforming recent pharma IPOs in terms of premium and demand.
Should I invest in Anlon Healthcare IPO based on GMP?
If you're targeting listing gains, yes. For long-term investment, assess regulatory and financial risks.
How much is the Anlon Healthcare IPO grey market premium?
₹20–₹25 per share as of August 25, 2025.
What is the Anlon Healthcare IPO subscription date GMP?
The IPO opens on August 26, 2025. GMP has been rising ahead of the subscription window.
What is the Anlon Healthcare IPO issue size GMP?
₹121.03 crore, with GMP suggesting strong demand and potential oversubscription.
Conclusion: Anlon Healthcare IPO GMP Reflects Strong Market Sentiment
The Anlon Healthcare IPO GMP, currently hovering between ₹20–₹25, signals robust demand and a promising listing outlook. With an estimated gain of over 25% and a price band of ₹86–₹91, the IPO stands out among recent SME healthcare offerings.
While the grey market premium suggests short-term upside, investors should also weigh long-term fundamentals, including regulatory exposure, financial scalability, and global expansion plans. The low retail quota and rising GMP make this IPO particularly attractive for listing gains, but strategic allocation is key.
Stay tuned for daily GMP updates, subscription trends, and post-listing performance insights to make informed investment decisions.
Want to stay ahead of upcoming IPOs and read more such type of content? Subscribe to our newsletter for weekly IPO alerts, allotment updates, and expert analysis tailored for smart investors.
Want to stay ahead of upcoming IPOs and read more such type of content? Subscribe to our newsletter for weekly IPO alerts, allotment updates, and expert analysis tailored for smart investors.
